Armata Pharmaceuticals Inc. (ARMP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Armata Pharmaceuticals In...

    AMEX: ARMP · Real-Time Price · USD
    2.85
    -0.12 (-4.04%)
    At close: Sep 05, 2025, 3:58 PM
    2.85
    0.00%
    After-hours: Sep 05, 2025, 05:45 PM EDT

    Armata Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 5.17M 4.53M 5.51M 4.47M
    Cost of Revenue
    		 1.32M 33.77M 892K 20.02M
    Gross Profit
    		 3.85M -29.24M 4.62M -15.54M
    Operating Income
    		 -42.44M -40.89M -36.95M -23.82M
    Interest Income
    		 697K 179K 29K 5K
    Pretax Income
    		 -18.92M -69.05M -36.92M -23.16M
    Net Income
    		 -18.92M -69.05M -36.92M -23.16M
    Selling & General & Admin
    		 13.18M 11.65M 7.44M 8.28M
    Research & Development
    		 34.43M 33.77M 35.02M 20.02M
    Other Expenses
    		 n/a -33.77M -892K -20.02M
    Operating Expenses
    		 47.61M 11.65M 41.56M 8.28M
    Interest Expense
    		 10.74M 2.63M 29K 64K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 47.61M 45.42M 42.45M 28.3M
    Income Tax Expense
    		 n/a n/a -29K n/a
    Shares Outstanding (Basic)
    		 36.16M 36.08M 34.29M 24.1M
    Shares Outstanding (Diluted)
    		 59.06M 36.08M 34.29M 24.1M
    EPS (Basic)
    		 -0.52 -1.91 -1.08 -0.96
    EPS (Diluted)
    		 -0.32 -1.91 -1.08 -0.96
    EBITDA
    		 -6.85M -39.92M -36.05M -22.65M
    EBIT
    		 -8.17M -40.89M -36.92M -23.09M
    Depreciation & Amortization
    		 1.32M 972K 892K 1.17M

    Add to Watchlist